Sickle Cell Disease
803
133
187
401
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
172 trials with published results (21%)
Research Maturity
401 completed trials (50% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
10.5%
84 terminated out of 803 trials
82.7%
-3.8% vs benchmark
11%
89 trials in Phase 3/4
43%
172 of 401 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 401 completed trials
Clinical Trials (803)
Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait
Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
Effects of the Contraceptive Implant in Women With Sickle Cell Disease
Best Noninvasive Predictor of Renal Function in Assessing Adult Sickle Nephropathy
Expanded Access Protocol for Gene Therapy Utilizing shmiR Lentivirus Vector to Induce Fetal Hemoglobin in Sickle Cell Disease
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Living With Sickle Cell Disease in the COVID-19 Pandemic
A Study to Learn About Sickle Cell Disease In Adult Patients
Investigation of the Genetics of Hematologic Diseases
Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Blood Sampling for Research Related to Sickle Cell Disease
Blood Collection for Research Related to Certain Diseases Involving Blood Vessels
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
Functional Ovarian Reserve in Sickle Cell Disease
Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
Allo HSCT for High Risk Hemoglobinopathies
Sickle Cell Clinical Research and Intervention Program